Oncology Institute of Southern Switzerland (IOSI)

PROSTATE CANCER
PRECEPTORSHIP

10 - 11 September 2026 • Bellinzona, Switzerland

View Programme General Info
Prostate Cancer Preceptorship
--- AGENDA ---

SCIENTIFIC PROGRAMME

Day 1
10th September
09.00 - 09.15
Welcome and presentation of the Oncology Institute and prostate cancer center of Southern Switzerland (IOSI/CPSI)
Dr. Silke Gillessen
Dr. Ursula Vogl
Dr. Yüksel Ürün
09.15 - 10.15
High risk /locally advanced prostate cancer – a spectrum of challenges and strategies
09.15 - 09.20
Opening clinical case
Dr. Daniele Brenna
09.20 - 09.35
- Perioperative systemic treatment in patients planned for prostatectomy- an option?
Dr. Nicola Fossati
09.35 - 09.55
- Intensification of systemic therapy for patients planned for curative radiotherapy – for all?
Dr. Thomas Zilli
09.55 - 10.15
Q&A Discussion
10.15 - 11.00
High-risk biochemical recurrence
10.15 - 10.20
Opening clinical case
Dr. Ursula Vogl
10.20 - 10.40
Debate: Intensification with ARPI for all patients with high-risk BCR

YES for all

NO only for selected patients


Dr. Fabio Turco

Dr. Gianmarco Leone
10.40 - 11.00
Q&A Discussion
11.00 - 11.20
Coffee Break
11.20 - 12.35
Metastatic hormone-sensitive prostate cancer (mHSPC)
11.20 - 11.50
Keynote Lecture

Current systemic treatment options in metastatic hormone - sensitive prostate cancer (mHSPC)
Dr. Silke Gillessen
11.50 - 11.55
Opening clinical case
Dr. Marialuisa Puglisi
11.55 - 12.15
The role of radiotherapy in mHSPC – (RT to the primary and metastatic directed therapy)
Dr. Salvatore Cozzi
12.15 - 12.35
Q&A Discussion
12.35 - 12.50
Investigator initiated clinical trials in Switzerland
(the IOSI and Swiss Cancer Institute – SCI experience)
Dr. Ursula Vogl
12.50 - 14.00
Lunch
14.00 - 14.30
Transfer to the Institute of Oncology Research (IOR) - 20 min walking
14.30 - 14.40
Opening and welcome to the IOR
Dr. Andrea Alimonti
14.40 - 15.00
Low-risk management
Dr. Nicolò Pernigoni
15.00 - 15.10
Q&A Discussion
15.10 - 15.30
Intermediate-risk management
Dr. Martino Maddalena
15.30 - 15.40
Q&A Discussion
15.40 - 16.00
Coffee Break
16.00 - 16.20
High-risk/Metastatic management
Dr. Gianmarco Leone
16.20 - 16.30
Q&A Discussion
16.30 - 17.30
Visit of the laboratory structures of the IOR
17.30
End of Day
Day 2
11th September
08.30 - 09.30
Androgen Pathway Modulator-Resistant Prostate Cancer / mCRPC
08.30 - 08.35
Opening Clinical Case
Dr. Cristina Lanzetta
08.35 - 09.05
Theranostics – from PSMA PET CT to radioligand therapy
Dr. Gaetano Paone
09.05 - 09.20
Taxane-based chemotherapy in mCRPC- still a role?
Dr. Ursula Vogl
09.20 - 09.40
Metabolic changes and bone health
Dr. Giovanna Pecoraro
09.40 - 10.00
Q&A Discussion
10.00 - 10.20
Coffee Break
10.20 - 11.20
Outlook - what to expect in the next 12 months for the treatment of advanced prostate cancer
10.20 - 10.40
- The urologist's view
Dr. Andrea Gallina
10.40 - 11.00
- The oncologist's view
Dr. Martino Pedrani
11.00 - 11.20
- The radiotherapist's view
Dr. Thomas Zilli
11.20 - 12.00
Tumorboard simulation

- Clinical cases 1
- Clinical cases 2
- Clinical cases 3
- Clinical cases 4
- Clinical cases 5
- Clinical cases 6

Panelists


Dr. Rolf Wyttenbach
Dr. Gaetano Paone
Dr. Manuela Bergmann
Dr. Andrea Gallina
Dr. Thomas Zilli
Dr. Ursula Vogl

Dr. Çağatay Arslan
Dr. Burak Bilgin
Dr. Emre Hafızoğlu
Dr. Gökşen İnanç İmamoğlu
Dr. Oğuzhan Kesen
Dr. Fatih Köse
Dr. Tolga Köşeci
Dr. Ahmet Oruç
12.00 - 12.15
Closing Remarks
--- COMMITTEES ---

COMMITTEES & SPEAKERS

Institute of Oncology Research (IOR)

Dr. Andrea Alimonti

Dr. Nicolò Pernigoni

Dr. Martino Maddalena

Dr. Gianmarco Leone

Speakers

Medical Oncologists

  • Dr. Silke Gillessen - Director of the Oncology Institute of Southern Switzerland
  • Dr. Ursula Vogl - Director of the Prostate Cancer Center of Southern Switzerland
  • Dr. Fabio Turco - Medical Oncologist
  • Dr. Gianmarco Leone - Medical Oncologist, Researcher IOR
  • Dr. Martino Pedrani - Medical Oncologist / Fase I Unit
  • Dr. Giovanna Pecoraro - Medical Oncologist
  • Dr. Cristina Lanzetta - Oncology Fellow GU Group IOSI
  • Dr. Marialuisa Puglisi - Medical Oncologist / Radiotherapy

Radiotherapist

  • Dr. Thomas Zilli - Head of the Radiotherapy Department of the IOSI
  • Dr. Salvatore Cozzi - Radiotherapist
  • Dr. Daniele Brenna - Medical Assistant in Radiotherapy

Urologist

  • Dr. Andrea Gallina - Head of the Urology Department EOC Lugano
  • Dr. Nicola Fossati - Deputy Head of the Urology Department EOC Lugano, Bellinzona

Nuclear Medicine Physician

  • Dr. Gaetano Paone - Head of Nuclear Medicine Department

Radiologist

  • Dr. Rolf Wyttenbach - Head of Imaging Department, Bellinzona

Pathology

  • Dr. Manuela Bergmann - Pathologist, Locarno

Panelists

  • Dr. Çağatay Arslan Medical Point Hospital, İzmir
  • Dr. Burak Bilgin Bilkent City Hospital, Ankara
  • Dr. Emre Hafızoğlu Bursa City Hospital, Bursa
  • Dr. Gökşen İnanç İmamoğlu Etlik City Hospital, Ankara
  • Dr. Oğuzhan Kesen Recep Tayyip Erdoğan University, Rize
  • Dr. Fatih Köse Başkent University, Adana
  • Dr. Tolga Köşeci Çukurova University, Adana
  • Dr. Ahmet Oruç Necmettin Erbakan University, Konya
--- INFORMATION ---

GENERAL INFORMATION

Meeting Date

September 09-11, 2026

Venue

Oncology Institute of Southern Switzerland (IOSI)

Language

Official language is English.

Certificate

Certificate of attendance will be e-mailed.

Letter of invitation and VISA

An official personalized letter of invitation will be provided to registered participants as part of the registration procedure. This invitation is prepared solely for the purpose of visa applications and is not a commitment on the part of the organizer’s to provide any financial support or confirmation of inclusion in the Scientific Program.